Mitotic Slippage: How It Affects Genome Stability
Explore how mitotic slippage influences genome stability and its implications for cancer development and cellular processes.
Explore how mitotic slippage influences genome stability and its implications for cancer development and cellular processes.
Mitotic slippage is a cellular process that significantly influences genome stability. It occurs when cells exit mitosis without proper chromosome segregation due to prolonged activation of the spindle assembly checkpoint, leading to polyploidy or aneuploidy—conditions associated with diseases like cancer.
Understanding mitotic slippage is crucial for grasping its implications on cellular health and disease progression. It affects genome integrity and contributes to tumorigenesis, highlighting its role in disrupting normal cellular functions.
Mitotic progression ensures accurate chromosome segregation and cell division. Central to this process is the mitotic spindle, composed of microtubules that attach to kinetochores at chromosome centromeres, aligning them at the metaphase plate. The spindle assembly checkpoint (SAC) monitors attachment and tension, preventing premature progression to anaphase.
The transition from metaphase to anaphase is governed by the anaphase-promoting complex/cyclosome (APC/C), which targets securin and cyclin B for degradation, activating separase to cleave cohesin complexes. This degradation is essential for chromatid separation and movement to opposite poles. The SAC regulates APC/C activity, inhibiting its function until chromosomes are properly attached.
As cells progress through anaphase, the mitotic spindle elongates, and cytokinesis occurs, dividing the cytoplasm through a contractile ring of actin and myosin filaments. Completion of cytokinesis marks the end of mitosis and the beginning of the G1 phase, where cells resume normal functions.
The spindle assembly checkpoint (SAC) is crucial for accurate chromosome segregation, acting as a safeguard for genomic stability. It activates in response to unattached or improperly tensioned kinetochores, halting the cell cycle at metaphase until all chromosomes align correctly. The SAC inhibits the anaphase-promoting complex/cyclosome (APC/C) through the mitotic checkpoint complex (MCC), which includes proteins like Mad2, BubR1, and Bub3, preventing premature anaphase onset.
Studies highlight the interplay between SAC components and the microtubule-kinetochore interface. Aurora B kinase regulates tension and attachment by phosphorylating kinetochore substrates, influencing the SAC’s response. This dynamic response ensures the cell does not proceed to anaphase until all chromosomes are stable.
The SAC’s robustness is underscored by its adaptability. In cancer cells, SAC function may be compromised, leading to chromosomal instability. Some tumor cells exhibit an overactive SAC, resulting in prolonged mitotic arrest and mitotic slippage, where cells exit mitosis without proper chromosome segregation. Targeting SAC components therapeutically is explored in cancer treatment, with inhibitors of Aurora B kinase or drugs that modulate microtubule dynamics being investigated.
Mitotic slippage, where cells exit mitosis without proper chromosome segregation, poses challenges to genome integrity. Cells often become polyploid or aneuploid, disrupting gene expression and cellular functions. Polyploidy might offer initial survival advantages but predisposes to further instability. Aneuploidy misregulates genes and proteins, impairing cellular homeostasis.
The consequences extend beyond immediate chromosomal missegregation. Genomic aberrations accumulate, leading to structural changes like deletions or translocations, compromising DNA repair mechanisms. Studies document increased DNA breaks and replication stress in cells undergoing slippage, exacerbating dysfunction.
The impact varies across cell types. Some cells activate compensatory pathways, while others lack such responses. Certain stem cell populations maintain pluripotency despite chromosomal aberrations, while differentiated cells often exhibit reduced adaptability, leading to senescence or apoptosis.
Mitotic slippage’s contribution to tumorigenesis highlights its role in cancer development. Cells bypassing mitotic arrest induced by the SAC result in aneuploidy, a common cancer feature. Irregular chromosome numbers disrupt oncogenes and tumor suppressor genes, fostering malignant transformation. This genomic instability provides fertile ground for cancerous phenotypes, enabling selection of cells with growth advantages.
Polyploid cells from slippage undergo further genomic alterations, producing variable progeny with distinct characteristics. This diversity within a tumor cell population can lead to therapy resistance and more aggressive cancer forms, challenging conventional treatments.
The interplay between p31^comet and mitotic slippage illustrates cellular responses to checkpoint signals. As a key SAC regulator, p31^comet silences the checkpoint once chromosomes are correctly attached. By binding to Mad2, a core SAC component, p31^comet facilitates mitotic checkpoint complex disassembly, promoting metaphase to anaphase transition.
In mitotic slippage, p31^comet’s role is critical. It influences the duration of mitotic arrest, impacting slippage propensity. Research shows that altered p31^comet expression affects cells’ ability to withstand prolonged arrest, impacting genomic stability. This modulation of slippage dynamics underscores its therapeutic potential, particularly in cancer cells with compromised SAC regulation. By manipulating p31^comet activity, the mitotic response of tumor cells could be altered, leading to improved therapeutic outcomes.